119 related articles for article (PubMed ID: 22773372)
1. Nerve growth factor induces the expression of chaperone protein calreticulin in human epithelial ovarian cells.
Vera C; Tapia V; Kohan K; Gabler F; Ferreira A; Selman A; Vega M; Romero C
Horm Metab Res; 2012 Jul; 44(8):639-43. PubMed ID: 22773372
[TBL] [Abstract][Full Text] [Related]
2. The nerve growth factor alters calreticulin translocation from the endoplasmic reticulum to the cell surface and its signaling pathway in epithelial ovarian cancer cells.
Vera CA; Oróstica L; Gabler F; Ferreira A; Selman A; Vega M; Romero CA
Int J Oncol; 2017 Apr; 50(4):1261-1270. PubMed ID: 28260038
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase A receptor (trkA): a potential marker in epithelial ovarian cancer.
Tapia V; Gabler F; Muñoz M; Yazigi R; Paredes A; Selman A; Vega M; Romero C
Gynecol Oncol; 2011 Apr; 121(1):13-23. PubMed ID: 21236475
[TBL] [Abstract][Full Text] [Related]
4. Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer.
Campos X; Muñoz Y; Selman A; Yazigi R; Moyano L; Weinstein-Oppenheimer C; Lara HE; Romero C
Gynecol Oncol; 2007 Jan; 104(1):168-75. PubMed ID: 16935322
[TBL] [Abstract][Full Text] [Related]
5. NGF/TRKA Decrease miR-145-5p Levels in Epithelial Ovarian Cancer Cells.
Garrido MP; Torres I; Avila A; Chnaiderman J; Valenzuela-Valderrama M; Aramburo J; Oróstica L; Durán-Jara E; Lobos-Gonzalez L; Romero C
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081171
[TBL] [Abstract][Full Text] [Related]
6. Follicle-stimulating hormone promotes nerve growth factor and vascular endothelial growth factor expression in epithelial ovarian cells.
Garrido MP; Bruneau N; Vega M; Selman A; Tapia JC; Romero C
Histol Histopathol; 2020 Sep; 35(9):961-971. PubMed ID: 32369181
[TBL] [Abstract][Full Text] [Related]
7. Role of Nerve Growth Factor (NGF) and miRNAs in Epithelial Ovarian Cancer.
Retamales-Ortega R; Oróstica L; Vera C; Cuevas P; Hernández A; Hurtado I; Vega M; Romero C
Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245631
[TBL] [Abstract][Full Text] [Related]
8. Effect of estradiol on the expression of angiogenic factors in epithelial ovarian cancer.
Valladares M; Plaza-Parrochia F; Lépez M; López D; Gabler F; Gayan P; Selman A; Vega M; Romero C
Histol Histopathol; 2017 Nov; 32(11):1187-1196. PubMed ID: 28116735
[TBL] [Abstract][Full Text] [Related]
9. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
[TBL] [Abstract][Full Text] [Related]
10. Role of nerve growth factor and its TRKA receptor in normal ovarian and epithelial ovarian cancer angiogenesis.
Vera C; Tapia V; Vega M; Romero C
J Ovarian Res; 2014 Aug; 7():82. PubMed ID: 25296882
[TBL] [Abstract][Full Text] [Related]
11. NGF/TRKA Promotes ADAM17-Dependent Cleavage of P75 in Ovarian Cells: Elucidating a Pro-Tumoral Mechanism.
Garrido MP; Vallejos C; Girardi S; Gabler F; Selman A; López F; Vega M; Romero C
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216240
[TBL] [Abstract][Full Text] [Related]
12. Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells.
Kohan-Ivani K; Gabler F; Selman A; Vega M; Romero C
J Cancer Res Clin Oncol; 2016 Jan; 142(1):47-58. PubMed ID: 26091707
[TBL] [Abstract][Full Text] [Related]
13. Human epithelial-type ovarian tumour marker beta-2-microglobulin is regulated by the TGF-β signaling pathway.
Sun W; Gui L; Zuo X; Zhang L; Zhou D; Duan X; Ren W; Xu G
J Transl Med; 2016 Mar; 14():75. PubMed ID: 26983758
[TBL] [Abstract][Full Text] [Related]
14. Expression of adiponectin and its receptors is altered in epithelial ovarian tumors and ascites-derived ovarian cancer cell lines.
Tiwari A; Ocon-Grove OM; Hadley JA; Giles JR; Johnson PA; Ramachandran R
Int J Gynecol Cancer; 2015 Mar; 25(3):399-406. PubMed ID: 25700032
[TBL] [Abstract][Full Text] [Related]
15. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.
Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M
Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014
[TBL] [Abstract][Full Text] [Related]
16. The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium.
Dabrow MB; Francesco MR; McBrearty FX; Caradonna S
Gynecol Oncol; 1998 Oct; 71(1):29-37. PubMed ID: 9784315
[TBL] [Abstract][Full Text] [Related]
17. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma.
Davidson B; Reich R; Lazarovici P; Nesland JM; Skrede M; Risberg B; Tropé CG; Flørenes VA
Clin Cancer Res; 2003 Jun; 9(6):2248-59. PubMed ID: 12796393
[TBL] [Abstract][Full Text] [Related]
18. Expression and action of keratinocyte growth factor (KGF) in normal ovarian surface epithelium and ovarian cancer.
Parrott JA; Kim G; Mosher R; Skinner MK
Mol Cell Endocrinol; 2000 Sep; 167(1-2):77-87. PubMed ID: 11000522
[TBL] [Abstract][Full Text] [Related]
19. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
